Hereditary Cancer in Clinical Practice (Jan 2021)

Novel PHOX2B germline mutation in childhood medulloblastoma: a case report

  • Caiping Ke,
  • Xiaoshun Shi,
  • Allen Menglin Chen,
  • Chaoming Li,
  • Bifeng Jiang,
  • Kailing Huang,
  • Zhouxia Zheng,
  • Yanhui Liu,
  • Zhuona Chen,
  • Yingjun Luo,
  • Huaming Lin,
  • Jiexia Zhang

DOI
https://doi.org/10.1186/s13053-021-00170-5
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background Medulloblastoma is an aggressive brain tumor mostly found in children, few studies on pathogenic germline mutations predisposing this disease was reported. Case presentation We present an 11-year-old male with medulloblastoma, who harbors a de novo PHOX2B germline mutation as detected by whole exome sequencing (WES). Family history was negative. Sanger sequencing confirmed this mutation in peripheral blood, hair bulbs, urine and saliva. Identification of novel germline mutations is beneficial for childhood cancer screening. Conclusions This case revealed a de novo PHOX2B germline mutation as a potential cause of medulloblastoma in a child and suggests familial germline variant screening is useful when an affected family is considering having a second child.

Keywords